These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35750540)

  • 1. Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis.
    Soares GH; Sethi S; Hedges J; Jamieson L
    Vaccine; 2022 Jul; 40(32):4644-4653. PubMed ID: 35750540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Area-Level Disparities in Human Papillomavirus Vaccination Coverage Using Geospatial Analysis.
    Wheeler DC; Miller CA; Do EK; Ksinan AJ; Trogdon JG; Chukmaitov A; Fuemmeler BF
    Cancer Epidemiol Biomarkers Prev; 2021 Sep; 30(9):1689-1696. PubMed ID: 34172461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Human Papillomavirus Vaccination School-Entry Requirements and Vaccination Initiation.
    Ko JS; Goldbeck CS; Baughan EB; Klausner JD
    JAMA Pediatr; 2020 Sep; 174(9):861-867. PubMed ID: 32597928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring socio-demographic and geospatial variation in human papillomavirus vaccination uptake in Virginia.
    Staples JN; Nelamangala SL; Morris S; Wells K
    Vaccine; 2021 Sep; 39(38):5385-5390. PubMed ID: 34384637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands.
    Simons JJM; Vida N; Westra TA; Postma MJ
    Vaccine; 2020 Jun; 38(30):4687-4694. PubMed ID: 32451211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
    Milondzo T; Meyer JC; Dochez C; Burnett RJ
    Front Public Health; 2021; 9():598625. PubMed ID: 33681125
    [No Abstract]   [Full Text] [Related]  

  • 7. An innovative housing-related measure for individual socioeconomic status and human papillomavirus vaccination coverage: A population-based cross-sectional study.
    MacLaughlin KL; Jacobson RM; Sauver JLS; Jacobson DJ; Fan C; Wi CI; Finney Rutten LJ
    Vaccine; 2020 Sep; 38(39):6112-6119. PubMed ID: 32713679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.
    Lindley MC; Jeyarajah J; Yankey D; Curtis CR; Markowitz LE; Stokley S
    Hum Vaccin Immunother; 2016 Jun; 12(6):1519-27. PubMed ID: 27003108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012.
    Cullen KA; Stokley S; Markowitz LE
    Acad Pediatr; 2014; 14(5):497-504. PubMed ID: 24954170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
    Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
    BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
    Egbon M; Ojo T; Aliyu A; Bagudu ZS
    BMC Public Health; 2022 Aug; 22(1):1611. PubMed ID: 36002832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
    Moss JL; Reiter PL; Brewer NT
    Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas.
    Conrey R; Valencia V; Cioletti A; Williams-Brown MY
    Vaccine; 2020 May; 38(25):4119-4124. PubMed ID: 32349907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine Hesitancy Drives Low Human Papillomavirus Vaccination Coverage in Girls Attending Public Schools in South Africa.
    Khosa LA; Meyer JC; Motshwane FMM; Dochez C; Burnett RJ
    Front Public Health; 2022; 10():860809. PubMed ID: 35685759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geospatial patterns in human papillomavirus vaccination uptake: evidence from uninsured and publicly insured children in North Carolina.
    Trogdon JG; Ahn T
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):595-602. PubMed ID: 25576528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
    Marty R; Roze S; Bresse X; Largeron N; Smith-Palmer J
    BMC Cancer; 2013 Jan; 13():10. PubMed ID: 23298365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020.
    Beyen MW; Bulto GA; Chaka EE; Debelo BT; Roga EY; Wakgari N; Danusa KT; Fekene DB
    PLoS One; 2022; 17(7):e0271237. PubMed ID: 35830389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National and State-Specific Estimates of Settings of Receiving Human Papillomavirus Vaccination Among Adolescents in the United States.
    Lu PJ; Yankey D; Fredua B; Hung MC; Walker TY; Markowitz LE; Elam-Evans LD
    J Adolesc Health; 2021 Oct; 69(4):597-603. PubMed ID: 33867229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estimated impact of natural immunity on the effectiveness of human papillomavirus vaccination.
    Matthijsse SM; Hontelez JAC; Naber SK; van Rosmalen J; Rozemeijer K; Penning C; Bakker R; van Ballegooijen M; de Kok IMCM; de Vlas SJ
    Vaccine; 2015 Oct; 33(41):5357-5364. PubMed ID: 26348405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.